nodes	percent_of_prediction	percent_of_DWPC	metapath
Diclofenac—ABCC1—breast cancer	0.0932	0.269	CbGaD
Diclofenac—CXCL8—breast cancer	0.0825	0.238	CbGaD
Diclofenac—PTGS1—breast cancer	0.0421	0.121	CbGaD
Diclofenac—CYP1A1—breast cancer	0.0385	0.111	CbGaD
Diclofenac—CYP3A4—breast cancer	0.0246	0.0709	CbGaD
Diclofenac—PTGS2—breast cancer	0.0241	0.0694	CbGaD
Diclofenac—ABCC1—Idarubicin—breast cancer	0.0239	0.0652	CbGbCtD
Diclofenac—ALB—breast cancer	0.0214	0.0618	CbGaD
Diclofenac—ABCB1—breast cancer	0.0205	0.059	CbGaD
Diclofenac—CYP1A1—Toremifene—breast cancer	0.0178	0.0486	CbGbCtD
Diclofenac—UGT2B7—Epirubicin—breast cancer	0.0117	0.0319	CbGbCtD
Diclofenac—CYP2B6—Thiotepa—breast cancer	0.0112	0.0307	CbGbCtD
Diclofenac—SLCO1C1—Methotrexate—breast cancer	0.0111	0.0302	CbGbCtD
Diclofenac—ABCC1—Mitoxantrone—breast cancer	0.0103	0.028	CbGbCtD
Diclofenac—UGT1A1—Irinotecan—breast cancer	0.00983	0.0268	CbGbCtD
Diclofenac—ABCC4—Fluorouracil—breast cancer	0.00965	0.0263	CbGbCtD
Diclofenac—CYP1A2—Anastrozole—breast cancer	0.0087	0.0237	CbGbCtD
Diclofenac—ABCC1—Epirubicin—breast cancer	0.00831	0.0227	CbGbCtD
Diclofenac—ABCC1—Paclitaxel—breast cancer	0.00819	0.0224	CbGbCtD
Diclofenac—ABCC1—Irinotecan—breast cancer	0.00808	0.0221	CbGbCtD
Diclofenac—CYP1A2—Toremifene—breast cancer	0.00795	0.0217	CbGbCtD
Diclofenac—CYP2C9—Anastrozole—breast cancer	0.00783	0.0214	CbGbCtD
Diclofenac—CYP2B6—Raloxifene—breast cancer	0.0075	0.0205	CbGbCtD
Diclofenac—CYP2C8—Lapatinib—breast cancer	0.00749	0.0205	CbGbCtD
Diclofenac—ABCC1—Vinblastine—breast cancer	0.00719	0.0196	CbGbCtD
Diclofenac—ABCB1—Toremifene—breast cancer	0.00695	0.019	CbGbCtD
Diclofenac—CYP1A1—Tamoxifen—breast cancer	0.0065	0.0177	CbGbCtD
Diclofenac—CYP2C19—Lapatinib—breast cancer	0.00629	0.0172	CbGbCtD
Diclofenac—CYP3A4—Exemestane—breast cancer	0.00601	0.0164	CbGbCtD
Diclofenac—CYP2C9—Idarubicin—breast cancer	0.00594	0.0162	CbGbCtD
Diclofenac—ABCC1—Docetaxel—breast cancer	0.00592	0.0162	CbGbCtD
Diclofenac—SLC22A11—Methotrexate—breast cancer	0.00572	0.0156	CbGbCtD
Diclofenac—CYP2C8—Raloxifene—breast cancer	0.00568	0.0155	CbGbCtD
Diclofenac—ABCC4—Methotrexate—breast cancer	0.00532	0.0145	CbGbCtD
Diclofenac—CYP3A4—Letrozole—breast cancer	0.00511	0.0139	CbGbCtD
Diclofenac—ABCB1—Lapatinib—breast cancer	0.00507	0.0138	CbGbCtD
Diclofenac—CYP2E1—Tamoxifen—breast cancer	0.00502	0.0137	CbGbCtD
Diclofenac—CYP2B6—Tamoxifen—breast cancer	0.00495	0.0135	CbGbCtD
Diclofenac—CYP2E1—Mitoxantrone—breast cancer	0.0049	0.0134	CbGbCtD
Diclofenac—CYP3A4—Anastrozole—breast cancer	0.00456	0.0124	CbGbCtD
Diclofenac—ABCC1—Doxorubicin—breast cancer	0.00442	0.0121	CbGbCtD
Diclofenac—ABCC1—Methotrexate—breast cancer	0.00428	0.0117	CbGbCtD
Diclofenac—CYP3A4—Toremifene—breast cancer	0.00417	0.0114	CbGbCtD
Diclofenac—CYP3A4—Fulvestrant—breast cancer	0.00387	0.0106	CbGbCtD
Diclofenac—CYP2B6—Irinotecan—breast cancer	0.0038	0.0104	CbGbCtD
Diclofenac—CYP2C8—Tamoxifen—breast cancer	0.00375	0.0102	CbGbCtD
Diclofenac—ALB—Irinotecan—breast cancer	0.00373	0.0102	CbGbCtD
Diclofenac—ALB—Fluorouracil—breast cancer	0.00358	0.00977	CbGbCtD
Diclofenac—CYP3A4—Thiotepa—breast cancer	0.00345	0.00942	CbGbCtD
Diclofenac—SLC22A8—Methotrexate—breast cancer	0.00333	0.00908	CbGbCtD
Diclofenac—CYP2C9—Capecitabine—breast cancer	0.00325	0.00888	CbGbCtD
Diclofenac—CYP3A4—Ixabepilone—breast cancer	0.00316	0.00862	CbGbCtD
Diclofenac—CYP2C19—Tamoxifen—breast cancer	0.00315	0.00859	CbGbCtD
Diclofenac—CYP3A4—Lapatinib—breast cancer	0.00304	0.0083	CbGbCtD
Diclofenac—CYP2C8—Paclitaxel—breast cancer	0.00292	0.00797	CbGbCtD
Diclofenac—CYP1A2—Tamoxifen—breast cancer	0.00291	0.00793	CbGbCtD
Diclofenac—ABCB1—Vinorelbine—breast cancer	0.00281	0.00768	CbGbCtD
Diclofenac—CYP2C8—Fluorouracil—breast cancer	0.00277	0.00755	CbGbCtD
Diclofenac—CYP2C9—Tamoxifen—breast cancer	0.00262	0.00714	CbGbCtD
Diclofenac—ABCB1—Tamoxifen—breast cancer	0.00254	0.00693	CbGbCtD
Diclofenac—ABCB1—Mitoxantrone—breast cancer	0.00248	0.00676	CbGbCtD
Diclofenac—SLC22A6—Methotrexate—breast cancer	0.00232	0.00632	CbGbCtD
Diclofenac—CYP3A4—Raloxifene—breast cancer	0.0023	0.00629	CbGbCtD
Diclofenac—ABCB1—Gemcitabine—breast cancer	0.00219	0.00597	CbGbCtD
Diclofenac—CYP1A2—Fluorouracil—breast cancer	0.00214	0.00584	CbGbCtD
Diclofenac—CYP2B6—Doxorubicin—breast cancer	0.00208	0.00567	CbGbCtD
Diclofenac—CYP2C9—Paclitaxel—breast cancer	0.00204	0.00556	CbGbCtD
Diclofenac—ABCB1—Paclitaxel—breast cancer	0.00198	0.0054	CbGbCtD
Diclofenac—ALB—Methotrexate—breast cancer	0.00197	0.00539	CbGbCtD
Diclofenac—ABCB1—Irinotecan—breast cancer	0.00195	0.00532	CbGbCtD
Diclofenac—CYP2C9—Fluorouracil—breast cancer	0.00193	0.00526	CbGbCtD
Diclofenac—ABCB1—Vinblastine—breast cancer	0.00173	0.00473	CbGbCtD
Diclofenac—CYP3A4—Vinorelbine—breast cancer	0.00169	0.0046	CbGbCtD
Diclofenac—CYP3A4—Tamoxifen—breast cancer	0.00152	0.00415	CbGbCtD
Diclofenac—CYP3A4—Mitoxantrone—breast cancer	0.00148	0.00405	CbGbCtD
Diclofenac—ABCB1—Docetaxel—breast cancer	0.00143	0.0039	CbGbCtD
Diclofenac—CXCR1—adipose tissue—breast cancer	0.00131	0.034	CbGeAlD
Diclofenac—CYP3A4—Paclitaxel—breast cancer	0.00118	0.00323	CbGbCtD
Diclofenac—CYP3A4—Irinotecan—breast cancer	0.00117	0.00319	CbGbCtD
Diclofenac—CXCR1—bone marrow—breast cancer	0.00114	0.0295	CbGeAlD
Diclofenac—ABCB1—Doxorubicin—breast cancer	0.00107	0.00291	CbGbCtD
Diclofenac—CYP3A4—Vinblastine—breast cancer	0.00104	0.00284	CbGbCtD
Diclofenac—ABCB1—Methotrexate—breast cancer	0.00103	0.00282	CbGbCtD
Diclofenac—PLA2G2A—nipple—breast cancer	0.000862	0.0224	CbGeAlD
Diclofenac—CYP3A4—Docetaxel—breast cancer	0.000856	0.00234	CbGbCtD
Diclofenac—CXCL8—nipple—breast cancer	0.000853	0.0222	CbGeAlD
Diclofenac—ASIC1—adipose tissue—breast cancer	0.000778	0.0202	CbGeAlD
Diclofenac—ASIC1—female reproductive system—breast cancer	0.000715	0.0186	CbGeAlD
Diclofenac—CXCR1—lymph node—breast cancer	0.000703	0.0183	CbGeAlD
Diclofenac—ASIC1—adrenal gland—breast cancer	0.000698	0.0181	CbGeAlD
Diclofenac—ASIC1—female gonad—breast cancer	0.000651	0.0169	CbGeAlD
Diclofenac—CYP3A4—Doxorubicin—breast cancer	0.000638	0.00174	CbGbCtD
Diclofenac—ASIC1—endocrine gland—breast cancer	0.000605	0.0157	CbGeAlD
Diclofenac—PLA2G2A—epithelium—breast cancer	0.00058	0.0151	CbGeAlD
Diclofenac—KCNQ2—pituitary gland—breast cancer	0.000572	0.0149	CbGeAlD
Diclofenac—KCNQ3—female reproductive system—breast cancer	0.000569	0.0148	CbGeAlD
Diclofenac—TTR—embryo—breast cancer	0.000537	0.0139	CbGeAlD
Diclofenac—KCNQ2—female reproductive system—breast cancer	0.000523	0.0136	CbGeAlD
Diclofenac—PLA2G2A—endometrium—breast cancer	0.00052	0.0135	CbGeAlD
Diclofenac—CXCL8—endometrium—breast cancer	0.000515	0.0134	CbGeAlD
Diclofenac—ALB—mammary gland—breast cancer	0.000502	0.013	CbGeAlD
Diclofenac—KCNQ2—female gonad—breast cancer	0.000476	0.0124	CbGeAlD
Diclofenac—PLA2G2A—pituitary gland—breast cancer	0.000471	0.0122	CbGeAlD
Diclofenac—PLA2G2A—adipose tissue—breast cancer	0.000469	0.0122	CbGeAlD
Diclofenac—CXCL8—pituitary gland—breast cancer	0.000466	0.0121	CbGeAlD
Diclofenac—CXCL8—adipose tissue—breast cancer	0.000464	0.0121	CbGeAlD
Diclofenac—KCNQ2—endocrine gland—breast cancer	0.000443	0.0115	CbGeAlD
Diclofenac—PLA2G2A—female reproductive system—breast cancer	0.000431	0.0112	CbGeAlD
Diclofenac—PLA2G2A—adrenal gland—breast cancer	0.000421	0.0109	CbGeAlD
Diclofenac—ASIC1—lymph node—breast cancer	0.000418	0.0109	CbGeAlD
Diclofenac—CXCL8—adrenal gland—breast cancer	0.000416	0.0108	CbGeAlD
Diclofenac—CXCL8—bone marrow—breast cancer	0.000403	0.0105	CbGeAlD
Diclofenac—SLCO1C1—pituitary gland—breast cancer	0.000398	0.0103	CbGeAlD
Diclofenac—SLCO1C1—adipose tissue—breast cancer	0.000396	0.0103	CbGeAlD
Diclofenac—PLA2G2A—female gonad—breast cancer	0.000392	0.0102	CbGeAlD
Diclofenac—CXCL8—female gonad—breast cancer	0.000388	0.0101	CbGeAlD
Diclofenac—SCN4A—pituitary gland—breast cancer	0.000365	0.00949	CbGeAlD
Diclofenac—PLA2G2A—endocrine gland—breast cancer	0.000365	0.00948	CbGeAlD
Diclofenac—SCN4A—adipose tissue—breast cancer	0.000364	0.00946	CbGeAlD
Diclofenac—UGT2B7—female reproductive system—breast cancer	0.000363	0.00943	CbGeAlD
Diclofenac—TTR—pituitary gland—breast cancer	0.000356	0.00924	CbGeAlD
Diclofenac—SLC22A11—female reproductive system—breast cancer	0.000354	0.00919	CbGeAlD
Diclofenac—CYP2C8—mammary gland—breast cancer	0.000353	0.00917	CbGeAlD
Diclofenac—ABCC1—nipple—breast cancer	0.000343	0.00891	CbGeAlD
Diclofenac—CYP2C18—endocrine gland—breast cancer	0.000333	0.00865	CbGeAlD
Diclofenac—SCN4A—adrenal gland—breast cancer	0.000326	0.00848	CbGeAlD
Diclofenac—TTR—female reproductive system—breast cancer	0.000325	0.00846	CbGeAlD
Diclofenac—ALOX5—adipose tissue—breast cancer	0.000321	0.00834	CbGeAlD
Diclofenac—CYP2C9—mammary gland—breast cancer	0.000313	0.00814	CbGeAlD
Diclofenac—SLCO1C1—endocrine gland—breast cancer	0.000308	0.008	CbGeAlD
Diclofenac—TTR—bone marrow—breast cancer	0.000307	0.00798	CbGeAlD
Diclofenac—UGT2B7—endocrine gland—breast cancer	0.000307	0.00798	CbGeAlD
Diclofenac—SLC22A11—endocrine gland—breast cancer	0.000299	0.00777	CbGeAlD
Diclofenac—ALOX5—female reproductive system—breast cancer	0.000295	0.00766	CbGeAlD
Diclofenac—ALOX5—adrenal gland—breast cancer	0.000288	0.00748	CbGeAlD
Diclofenac—ALOX5—bone marrow—breast cancer	0.000278	0.00723	CbGeAlD
Diclofenac—TTR—endocrine gland—breast cancer	0.000275	0.00716	CbGeAlD
Diclofenac—CYP1A2—nipple—breast cancer	0.000273	0.0071	CbGeAlD
Diclofenac—Bromfenac—PTGS1—breast cancer	0.00027	0.123	CrCbGaD
Diclofenac—CYP1A1—nipple—breast cancer	0.000269	0.007	CbGeAlD
Diclofenac—ALOX5—female gonad—breast cancer	0.000268	0.00697	CbGeAlD
Diclofenac—UGT1A1—endocrine gland—breast cancer	0.000261	0.00678	CbGeAlD
Diclofenac—PLA2G2A—lymph node—breast cancer	0.000252	0.00655	CbGeAlD
Diclofenac—CXCL8—lymph node—breast cancer	0.00025	0.00649	CbGeAlD
Diclofenac—ALOX5—endocrine gland—breast cancer	0.00025	0.00648	CbGeAlD
Diclofenac—PTGS1—nipple—breast cancer	0.000237	0.00615	CbGeAlD
Diclofenac—Lumiracoxib—PTGS1—breast cancer	0.00023	0.105	CrCbGaD
Diclofenac—ABCC4—uterus—breast cancer	0.000224	0.00581	CbGeAlD
Diclofenac—ABCC4—adipose tissue—breast cancer	0.000219	0.00568	CbGeAlD
Diclofenac—Nepafenac—PTGS1—breast cancer	0.000219	0.0999	CrCbGaD
Diclofenac—SLCO1C1—lymph node—breast cancer	0.000213	0.00553	CbGeAlD
Diclofenac—ABCC1—endometrium—breast cancer	0.000207	0.00538	CbGeAlD
Diclofenac—ALB—adrenal gland—breast cancer	0.000203	0.00527	CbGeAlD
Diclofenac—ABCC4—female reproductive system—breast cancer	0.000201	0.00522	CbGeAlD
Diclofenac—ABCC4—adrenal gland—breast cancer	0.000196	0.0051	CbGeAlD
Diclofenac—ABCC1—uterus—breast cancer	0.000191	0.00495	CbGeAlD
Diclofenac—ABCC4—bone marrow—breast cancer	0.00019	0.00493	CbGeAlD
Diclofenac—ABCC1—pituitary gland—breast cancer	0.000187	0.00487	CbGeAlD
Diclofenac—PTGS2—embryo—breast cancer	0.000187	0.00485	CbGeAlD
Diclofenac—ABCC1—adipose tissue—breast cancer	0.000187	0.00485	CbGeAlD
Diclofenac—ABCC4—female gonad—breast cancer	0.000183	0.00475	CbGeAlD
Diclofenac—CYP1A1—epithelium—breast cancer	0.000181	0.00471	CbGeAlD
Diclofenac—Meclofenamic acid—PTGS1—breast cancer	0.000179	0.0818	CrCbGaD
Diclofenac—CYP2C8—endometrium—breast cancer	0.000176	0.00458	CbGeAlD
Diclofenac—CYP1A1—skin of body—breast cancer	0.000173	0.00448	CbGeAlD
Diclofenac—ALOX5—lymph node—breast cancer	0.000173	0.00448	CbGeAlD
Diclofenac—ABCC4—endocrine gland—breast cancer	0.00017	0.00442	CbGeAlD
Diclofenac—CYP2B6—skin of body—breast cancer	0.000168	0.00436	CbGeAlD
Diclofenac—ABCC1—adrenal gland—breast cancer	0.000167	0.00435	CbGeAlD
Diclofenac—Guanfacine—CYP3A4—breast cancer	0.000165	0.0752	CrCbGaD
Diclofenac—CYP2C8—pituitary gland—breast cancer	0.000159	0.00414	CbGeAlD
Diclofenac—PTGS1—epithelium—breast cancer	0.000159	0.00414	CbGeAlD
Diclofenac—ABCC1—female gonad—breast cancer	0.000156	0.00405	CbGeAlD
Diclofenac—Bromfenac—PTGS2—breast cancer	0.000155	0.0706	CrCbGaD
Diclofenac—PTGS2—epithelium—breast cancer	0.000152	0.00396	CbGeAlD
Diclofenac—PTGS1—skin of body—breast cancer	0.000152	0.00394	CbGeAlD
Diclofenac—CYP1A1—uterus—breast cancer	0.00015	0.00389	CbGeAlD
Diclofenac—CYP1A1—adipose tissue—breast cancer	0.000147	0.00381	CbGeAlD
Diclofenac—CYP2C8—female reproductive system—breast cancer	0.000146	0.00379	CbGeAlD
Diclofenac—PTGS2—skin of body—breast cancer	0.000145	0.00376	CbGeAlD
Diclofenac—PTGS1—endometrium—breast cancer	0.000143	0.00371	CbGeAlD
Diclofenac—CYP2C19—endocrine gland—breast cancer	0.000142	0.00368	CbGeAlD
Diclofenac—Mefenamic acid—PTGS1—breast cancer	0.000139	0.0636	CrCbGaD
Diclofenac—PTGS2—endometrium—breast cancer	0.000137	0.00355	CbGeAlD
Diclofenac—Clonidine—CYP1A1—breast cancer	0.000135	0.0619	CrCbGaD
Diclofenac—CYP1A1—female reproductive system—breast cancer	0.000135	0.0035	CbGeAlD
Diclofenac—PTGS1—uterus—breast cancer	0.000132	0.00342	CbGeAlD
Diclofenac—Lumiracoxib—PTGS2—breast cancer	0.000131	0.06	CrCbGaD
Diclofenac—CYP2B6—female reproductive system—breast cancer	0.000131	0.0034	CbGeAlD
Diclofenac—CYP2C9—female reproductive system—breast cancer	0.00013	0.00337	CbGeAlD
Diclofenac—PTGS1—pituitary gland—breast cancer	0.000129	0.00336	CbGeAlD
Diclofenac—PTGS1—adipose tissue—breast cancer	0.000129	0.00335	CbGeAlD
Diclofenac—CYP2B6—adrenal gland—breast cancer	0.000128	0.00332	CbGeAlD
Diclofenac—PTGS2—uterus—breast cancer	0.000126	0.00327	CbGeAlD
Diclofenac—Nepafenac—PTGS2—breast cancer	0.000125	0.0571	CrCbGaD
Diclofenac—PTGS2—pituitary gland—breast cancer	0.000124	0.00321	CbGeAlD
Diclofenac—CYP2C8—endocrine gland—breast cancer	0.000124	0.00321	CbGeAlD
Diclofenac—PTGS2—adipose tissue—breast cancer	0.000123	0.0032	CbGeAlD
Diclofenac—CYP2E1—female reproductive system—breast cancer	0.000123	0.00319	CbGeAlD
Diclofenac—CYP1A1—female gonad—breast cancer	0.000123	0.00319	CbGeAlD
Diclofenac—ALB—lymph node—breast cancer	0.000122	0.00316	CbGeAlD
Diclofenac—CYP2E1—adrenal gland—breast cancer	0.00012	0.00312	CbGeAlD
Diclofenac—PTGS1—female reproductive system—breast cancer	0.000118	0.00308	CbGeAlD
Diclofenac—ABCC4—lymph node—breast cancer	0.000118	0.00306	CbGeAlD
Diclofenac—CYP1A2—endocrine gland—breast cancer	0.000116	0.003	CbGeAlD
Diclofenac—PTGS1—adrenal gland—breast cancer	0.000116	0.003	CbGeAlD
Diclofenac—ABCB1—embryo—breast cancer	0.000115	0.003	CbGeAlD
Diclofenac—CYP1A1—endocrine gland—breast cancer	0.000114	0.00296	CbGeAlD
Diclofenac—PTGS2—female reproductive system—breast cancer	0.000113	0.00294	CbGeAlD
Diclofenac—CYP2B6—endocrine gland—breast cancer	0.000111	0.00288	CbGeAlD
Diclofenac—PTGS2—adrenal gland—breast cancer	0.00011	0.00287	CbGeAlD
Diclofenac—CYP2C9—endocrine gland—breast cancer	0.00011	0.00285	CbGeAlD
Diclofenac—PTGS1—female gonad—breast cancer	0.000108	0.0028	CbGeAlD
Diclofenac—PTGS2—bone marrow—breast cancer	0.000107	0.00278	CbGeAlD
Diclofenac—CYP2E1—endocrine gland—breast cancer	0.000104	0.0027	CbGeAlD
Diclofenac—PTGS2—female gonad—breast cancer	0.000103	0.00267	CbGeAlD
Diclofenac—Meclofenamic acid—PTGS2—breast cancer	0.000102	0.0468	CrCbGaD
Diclofenac—Clonidine—CYP2D6—breast cancer	0.000101	0.046	CrCbGaD
Diclofenac—ABCC1—lymph node—breast cancer	0.0001	0.00261	CbGeAlD
Diclofenac—PTGS1—endocrine gland—breast cancer	0.0001	0.0026	CbGeAlD
Diclofenac—CYP3A4—female reproductive system—breast cancer	9.89e-05	0.00257	CbGeAlD
Diclofenac—PTGS2—endocrine gland—breast cancer	9.57e-05	0.00249	CbGeAlD
Diclofenac—ABCB1—epithelium—breast cancer	9.42e-05	0.00245	CbGeAlD
Diclofenac—Clonidine—CYP3A4—breast cancer	8.65e-05	0.0395	CrCbGaD
Diclofenac—ABCB1—endometrium—breast cancer	8.45e-05	0.00219	CbGeAlD
Diclofenac—CYP3A4—endocrine gland—breast cancer	8.37e-05	0.00217	CbGeAlD
Diclofenac—Mefenamic acid—PTGS2—breast cancer	7.96e-05	0.0364	CrCbGaD
Diclofenac—CYP1A1—lymph node—breast cancer	7.88e-05	0.00205	CbGeAlD
Diclofenac—ABCB1—uterus—breast cancer	7.79e-05	0.00202	CbGeAlD
Diclofenac—ABCB1—pituitary gland—breast cancer	7.65e-05	0.00199	CbGeAlD
Diclofenac—ABCB1—adipose tissue—breast cancer	7.61e-05	0.00198	CbGeAlD
Diclofenac—Clonidine—ABCB1—breast cancer	7.2e-05	0.0329	CrCbGaD
Diclofenac—ABCB1—female reproductive system—breast cancer	7e-05	0.00182	CbGeAlD
Diclofenac—PTGS1—lymph node—breast cancer	6.92e-05	0.0018	CbGeAlD
Diclofenac—ABCB1—adrenal gland—breast cancer	6.83e-05	0.00177	CbGeAlD
Diclofenac—PTGS2—lymph node—breast cancer	6.62e-05	0.00172	CbGeAlD
Diclofenac—ABCB1—bone marrow—breast cancer	6.61e-05	0.00172	CbGeAlD
Diclofenac—ABCB1—female gonad—breast cancer	6.37e-05	0.00165	CbGeAlD
Diclofenac—ABCB1—endocrine gland—breast cancer	5.92e-05	0.00154	CbGeAlD
Diclofenac—ABCB1—lymph node—breast cancer	4.09e-05	0.00106	CbGeAlD
Diclofenac—Urethral disorder—Doxorubicin—breast cancer	1.39e-05	9.82e-05	CcSEcCtD
Diclofenac—Nausea—Irinotecan—breast cancer	1.39e-05	9.8e-05	CcSEcCtD
Diclofenac—Nausea—Mitoxantrone—breast cancer	1.39e-05	9.8e-05	CcSEcCtD
Diclofenac—Immune system disorder—Epirubicin—breast cancer	1.38e-05	9.78e-05	CcSEcCtD
Diclofenac—Mediastinal disorder—Epirubicin—breast cancer	1.38e-05	9.76e-05	CcSEcCtD
Diclofenac—Constipation—Docetaxel—breast cancer	1.38e-05	9.75e-05	CcSEcCtD
Diclofenac—Pain—Docetaxel—breast cancer	1.38e-05	9.75e-05	CcSEcCtD
Diclofenac—Back pain—Methotrexate—breast cancer	1.38e-05	9.74e-05	CcSEcCtD
Diclofenac—Dyspepsia—Capecitabine—breast cancer	1.37e-05	9.72e-05	CcSEcCtD
Diclofenac—Chills—Epirubicin—breast cancer	1.37e-05	9.72e-05	CcSEcCtD
Diclofenac—Arrhythmia—Epirubicin—breast cancer	1.37e-05	9.67e-05	CcSEcCtD
Diclofenac—Visual impairment—Doxorubicin—breast cancer	1.36e-05	9.66e-05	CcSEcCtD
Diclofenac—Asthenia—Paclitaxel—breast cancer	1.36e-05	9.66e-05	CcSEcCtD
Diclofenac—Decreased appetite—Capecitabine—breast cancer	1.36e-05	9.6e-05	CcSEcCtD
Diclofenac—Alopecia—Epirubicin—breast cancer	1.35e-05	9.57e-05	CcSEcCtD
Diclofenac—Nausea—Gemcitabine—breast cancer	1.35e-05	9.55e-05	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Capecitabine—breast cancer	1.35e-05	9.53e-05	CcSEcCtD
Diclofenac—Fatigue—Capecitabine—breast cancer	1.35e-05	9.52e-05	CcSEcCtD
Diclofenac—Pruritus—Paclitaxel—breast cancer	1.35e-05	9.52e-05	CcSEcCtD
Diclofenac—Vision blurred—Methotrexate—breast cancer	1.34e-05	9.49e-05	CcSEcCtD
Diclofenac—Mental disorder—Epirubicin—breast cancer	1.34e-05	9.49e-05	CcSEcCtD
Diclofenac—Erythema multiforme—Doxorubicin—breast cancer	1.34e-05	9.47e-05	CcSEcCtD
Diclofenac—Constipation—Capecitabine—breast cancer	1.33e-05	9.44e-05	CcSEcCtD
Diclofenac—Pain—Capecitabine—breast cancer	1.33e-05	9.44e-05	CcSEcCtD
Diclofenac—Malnutrition—Epirubicin—breast cancer	1.33e-05	9.43e-05	CcSEcCtD
Diclofenac—Erythema—Epirubicin—breast cancer	1.33e-05	9.43e-05	CcSEcCtD
Diclofenac—Feeling abnormal—Docetaxel—breast cancer	1.33e-05	9.4e-05	CcSEcCtD
Diclofenac—Nausea—Fluorouracil—breast cancer	1.33e-05	9.39e-05	CcSEcCtD
Diclofenac—Eye disorder—Doxorubicin—breast cancer	1.32e-05	9.36e-05	CcSEcCtD
Diclofenac—Ill-defined disorder—Methotrexate—breast cancer	1.32e-05	9.35e-05	CcSEcCtD
Diclofenac—Tinnitus—Doxorubicin—breast cancer	1.32e-05	9.34e-05	CcSEcCtD
Diclofenac—Gastrointestinal pain—Docetaxel—breast cancer	1.32e-05	9.33e-05	CcSEcCtD
Diclofenac—Anaemia—Methotrexate—breast cancer	1.32e-05	9.31e-05	CcSEcCtD
Diclofenac—Flushing—Doxorubicin—breast cancer	1.31e-05	9.3e-05	CcSEcCtD
Diclofenac—Cardiac disorder—Doxorubicin—breast cancer	1.31e-05	9.3e-05	CcSEcCtD
Diclofenac—Flatulence—Epirubicin—breast cancer	1.31e-05	9.29e-05	CcSEcCtD
Diclofenac—Tension—Epirubicin—breast cancer	1.31e-05	9.25e-05	CcSEcCtD
Diclofenac—Dysgeusia—Epirubicin—breast cancer	1.3e-05	9.23e-05	CcSEcCtD
Diclofenac—Diarrhoea—Paclitaxel—breast cancer	1.3e-05	9.21e-05	CcSEcCtD
Diclofenac—Nervousness—Epirubicin—breast cancer	1.29e-05	9.16e-05	CcSEcCtD
Diclofenac—Back pain—Epirubicin—breast cancer	1.29e-05	9.12e-05	CcSEcCtD
Diclofenac—Feeling abnormal—Capecitabine—breast cancer	1.29e-05	9.1e-05	CcSEcCtD
Diclofenac—Angiopathy—Doxorubicin—breast cancer	1.28e-05	9.09e-05	CcSEcCtD
Diclofenac—Malaise—Methotrexate—breast cancer	1.28e-05	9.08e-05	CcSEcCtD
Diclofenac—Muscle spasms—Epirubicin—breast cancer	1.28e-05	9.06e-05	CcSEcCtD
Diclofenac—Immune system disorder—Doxorubicin—breast cancer	1.28e-05	9.05e-05	CcSEcCtD
Diclofenac—Vertigo—Methotrexate—breast cancer	1.28e-05	9.05e-05	CcSEcCtD
Diclofenac—Gastrointestinal pain—Capecitabine—breast cancer	1.28e-05	9.03e-05	CcSEcCtD
Diclofenac—Mediastinal disorder—Doxorubicin—breast cancer	1.28e-05	9.03e-05	CcSEcCtD
Diclofenac—Abdominal pain—Docetaxel—breast cancer	1.27e-05	9.02e-05	CcSEcCtD
Diclofenac—Body temperature increased—Docetaxel—breast cancer	1.27e-05	9.02e-05	CcSEcCtD
Diclofenac—Leukopenia—Methotrexate—breast cancer	1.27e-05	9.02e-05	CcSEcCtD
Diclofenac—Chills—Doxorubicin—breast cancer	1.27e-05	8.99e-05	CcSEcCtD
Diclofenac—Arrhythmia—Doxorubicin—breast cancer	1.27e-05	8.95e-05	CcSEcCtD
Diclofenac—Dizziness—Paclitaxel—breast cancer	1.26e-05	8.9e-05	CcSEcCtD
Diclofenac—Vision blurred—Epirubicin—breast cancer	1.26e-05	8.88e-05	CcSEcCtD
Diclofenac—Alopecia—Doxorubicin—breast cancer	1.25e-05	8.85e-05	CcSEcCtD
Diclofenac—Cough—Methotrexate—breast cancer	1.24e-05	8.79e-05	CcSEcCtD
Diclofenac—Mental disorder—Doxorubicin—breast cancer	1.24e-05	8.78e-05	CcSEcCtD
Diclofenac—Urticaria—Capecitabine—breast cancer	1.24e-05	8.77e-05	CcSEcCtD
Diclofenac—Ill-defined disorder—Epirubicin—breast cancer	1.24e-05	8.75e-05	CcSEcCtD
Diclofenac—Abdominal pain—Capecitabine—breast cancer	1.23e-05	8.73e-05	CcSEcCtD
Diclofenac—Body temperature increased—Capecitabine—breast cancer	1.23e-05	8.73e-05	CcSEcCtD
Diclofenac—Convulsion—Methotrexate—breast cancer	1.23e-05	8.73e-05	CcSEcCtD
Diclofenac—Erythema—Doxorubicin—breast cancer	1.23e-05	8.72e-05	CcSEcCtD
Diclofenac—Malnutrition—Doxorubicin—breast cancer	1.23e-05	8.72e-05	CcSEcCtD
Diclofenac—Anaemia—Epirubicin—breast cancer	1.23e-05	8.71e-05	CcSEcCtD
Diclofenac—Agitation—Epirubicin—breast cancer	1.22e-05	8.66e-05	CcSEcCtD
Diclofenac—Flatulence—Doxorubicin—breast cancer	1.21e-05	8.59e-05	CcSEcCtD
Diclofenac—Arthralgia—Methotrexate—breast cancer	1.21e-05	8.58e-05	CcSEcCtD
Diclofenac—Chest pain—Methotrexate—breast cancer	1.21e-05	8.58e-05	CcSEcCtD
Diclofenac—Myalgia—Methotrexate—breast cancer	1.21e-05	8.58e-05	CcSEcCtD
Diclofenac—Tension—Doxorubicin—breast cancer	1.21e-05	8.56e-05	CcSEcCtD
Diclofenac—Vomiting—Paclitaxel—breast cancer	1.21e-05	8.56e-05	CcSEcCtD
Diclofenac—Dysgeusia—Doxorubicin—breast cancer	1.21e-05	8.54e-05	CcSEcCtD
Diclofenac—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	1.2e-05	8.52e-05	CcSEcCtD
Diclofenac—Malaise—Epirubicin—breast cancer	1.2e-05	8.5e-05	CcSEcCtD
Diclofenac—Rash—Paclitaxel—breast cancer	1.2e-05	8.48e-05	CcSEcCtD
Diclofenac—Dermatitis—Paclitaxel—breast cancer	1.2e-05	8.48e-05	CcSEcCtD
Diclofenac—Discomfort—Methotrexate—breast cancer	1.2e-05	8.47e-05	CcSEcCtD
Diclofenac—Nervousness—Doxorubicin—breast cancer	1.2e-05	8.47e-05	CcSEcCtD
Diclofenac—Vertigo—Epirubicin—breast cancer	1.2e-05	8.47e-05	CcSEcCtD
Diclofenac—Syncope—Epirubicin—breast cancer	1.19e-05	8.45e-05	CcSEcCtD
Diclofenac—Leukopenia—Epirubicin—breast cancer	1.19e-05	8.44e-05	CcSEcCtD
Diclofenac—Back pain—Doxorubicin—breast cancer	1.19e-05	8.44e-05	CcSEcCtD
Diclofenac—Headache—Paclitaxel—breast cancer	1.19e-05	8.43e-05	CcSEcCtD
Diclofenac—Hypersensitivity—Docetaxel—breast cancer	1.19e-05	8.4e-05	CcSEcCtD
Diclofenac—Muscle spasms—Doxorubicin—breast cancer	1.19e-05	8.39e-05	CcSEcCtD
Diclofenac—Palpitations—Epirubicin—breast cancer	1.18e-05	8.33e-05	CcSEcCtD
Diclofenac—Confusional state—Methotrexate—breast cancer	1.17e-05	8.29e-05	CcSEcCtD
Diclofenac—Loss of consciousness—Epirubicin—breast cancer	1.17e-05	8.29e-05	CcSEcCtD
Diclofenac—Cough—Epirubicin—breast cancer	1.16e-05	8.23e-05	CcSEcCtD
Diclofenac—Anaphylactic shock—Methotrexate—breast cancer	1.16e-05	8.22e-05	CcSEcCtD
Diclofenac—Vision blurred—Doxorubicin—breast cancer	1.16e-05	8.22e-05	CcSEcCtD
Diclofenac—Asthenia—Docetaxel—breast cancer	1.16e-05	8.18e-05	CcSEcCtD
Diclofenac—Convulsion—Epirubicin—breast cancer	1.15e-05	8.17e-05	CcSEcCtD
Diclofenac—Infection—Methotrexate—breast cancer	1.15e-05	8.17e-05	CcSEcCtD
Diclofenac—Hypertension—Epirubicin—breast cancer	1.15e-05	8.14e-05	CcSEcCtD
Diclofenac—Hypersensitivity—Capecitabine—breast cancer	1.15e-05	8.14e-05	CcSEcCtD
Diclofenac—Ill-defined disorder—Doxorubicin—breast cancer	1.14e-05	8.09e-05	CcSEcCtD
Diclofenac—Pruritus—Docetaxel—breast cancer	1.14e-05	8.07e-05	CcSEcCtD
Diclofenac—Nervous system disorder—Methotrexate—breast cancer	1.14e-05	8.06e-05	CcSEcCtD
Diclofenac—Anaemia—Doxorubicin—breast cancer	1.14e-05	8.06e-05	CcSEcCtD
Diclofenac—Thrombocytopenia—Methotrexate—breast cancer	1.14e-05	8.05e-05	CcSEcCtD
Diclofenac—Arthralgia—Epirubicin—breast cancer	1.13e-05	8.03e-05	CcSEcCtD
Diclofenac—Chest pain—Epirubicin—breast cancer	1.13e-05	8.03e-05	CcSEcCtD
Diclofenac—Myalgia—Epirubicin—breast cancer	1.13e-05	8.03e-05	CcSEcCtD
Diclofenac—Agitation—Doxorubicin—breast cancer	1.13e-05	8.02e-05	CcSEcCtD
Diclofenac—Anxiety—Epirubicin—breast cancer	1.13e-05	8e-05	CcSEcCtD
Diclofenac—Nausea—Paclitaxel—breast cancer	1.13e-05	7.99e-05	CcSEcCtD
Diclofenac—Skin disorder—Methotrexate—breast cancer	1.13e-05	7.99e-05	CcSEcCtD
Diclofenac—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	1.13e-05	7.97e-05	CcSEcCtD
Diclofenac—Hyperhidrosis—Methotrexate—breast cancer	1.12e-05	7.95e-05	CcSEcCtD
Diclofenac—Discomfort—Epirubicin—breast cancer	1.12e-05	7.93e-05	CcSEcCtD
Diclofenac—Asthenia—Capecitabine—breast cancer	1.12e-05	7.92e-05	CcSEcCtD
Diclofenac—Malaise—Doxorubicin—breast cancer	1.11e-05	7.87e-05	CcSEcCtD
Diclofenac—Dry mouth—Epirubicin—breast cancer	1.11e-05	7.85e-05	CcSEcCtD
Diclofenac—Vertigo—Doxorubicin—breast cancer	1.11e-05	7.84e-05	CcSEcCtD
Diclofenac—Anorexia—Methotrexate—breast cancer	1.11e-05	7.84e-05	CcSEcCtD
Diclofenac—Syncope—Doxorubicin—breast cancer	1.11e-05	7.82e-05	CcSEcCtD
Diclofenac—Pruritus—Capecitabine—breast cancer	1.1e-05	7.81e-05	CcSEcCtD
Diclofenac—Leukopenia—Doxorubicin—breast cancer	1.1e-05	7.81e-05	CcSEcCtD
Diclofenac—Diarrhoea—Docetaxel—breast cancer	1.1e-05	7.8e-05	CcSEcCtD
Diclofenac—Confusional state—Epirubicin—breast cancer	1.1e-05	7.76e-05	CcSEcCtD
Diclofenac—Palpitations—Doxorubicin—breast cancer	1.09e-05	7.71e-05	CcSEcCtD
Diclofenac—Oedema—Epirubicin—breast cancer	1.09e-05	7.69e-05	CcSEcCtD
Diclofenac—Anaphylactic shock—Epirubicin—breast cancer	1.09e-05	7.69e-05	CcSEcCtD
Diclofenac—Hypotension—Methotrexate—breast cancer	1.09e-05	7.68e-05	CcSEcCtD
Diclofenac—Loss of consciousness—Doxorubicin—breast cancer	1.08e-05	7.67e-05	CcSEcCtD
Diclofenac—Infection—Epirubicin—breast cancer	1.08e-05	7.64e-05	CcSEcCtD
Diclofenac—Cough—Doxorubicin—breast cancer	1.08e-05	7.61e-05	CcSEcCtD
Diclofenac—Shock—Epirubicin—breast cancer	1.07e-05	7.57e-05	CcSEcCtD
Diclofenac—Convulsion—Doxorubicin—breast cancer	1.07e-05	7.56e-05	CcSEcCtD
Diclofenac—Diarrhoea—Capecitabine—breast cancer	1.07e-05	7.56e-05	CcSEcCtD
Diclofenac—Nervous system disorder—Epirubicin—breast cancer	1.07e-05	7.54e-05	CcSEcCtD
Diclofenac—Dizziness—Docetaxel—breast cancer	1.07e-05	7.54e-05	CcSEcCtD
Diclofenac—Thrombocytopenia—Epirubicin—breast cancer	1.06e-05	7.53e-05	CcSEcCtD
Diclofenac—Hypertension—Doxorubicin—breast cancer	1.06e-05	7.53e-05	CcSEcCtD
Diclofenac—Tachycardia—Epirubicin—breast cancer	1.06e-05	7.51e-05	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Methotrexate—breast cancer	1.06e-05	7.49e-05	CcSEcCtD
Diclofenac—Skin disorder—Epirubicin—breast cancer	1.06e-05	7.47e-05	CcSEcCtD
Diclofenac—Hyperhidrosis—Epirubicin—breast cancer	1.05e-05	7.44e-05	CcSEcCtD
Diclofenac—Insomnia—Methotrexate—breast cancer	1.05e-05	7.44e-05	CcSEcCtD
Diclofenac—Chest pain—Doxorubicin—breast cancer	1.05e-05	7.43e-05	CcSEcCtD
Diclofenac—Arthralgia—Doxorubicin—breast cancer	1.05e-05	7.43e-05	CcSEcCtD
Diclofenac—Myalgia—Doxorubicin—breast cancer	1.05e-05	7.43e-05	CcSEcCtD
Diclofenac—Anxiety—Doxorubicin—breast cancer	1.05e-05	7.4e-05	CcSEcCtD
Diclofenac—Paraesthesia—Methotrexate—breast cancer	1.04e-05	7.38e-05	CcSEcCtD
Diclofenac—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	1.04e-05	7.37e-05	CcSEcCtD
Diclofenac—Discomfort—Doxorubicin—breast cancer	1.04e-05	7.34e-05	CcSEcCtD
Diclofenac—Anorexia—Epirubicin—breast cancer	1.04e-05	7.33e-05	CcSEcCtD
Diclofenac—Dyspnoea—Methotrexate—breast cancer	1.04e-05	7.33e-05	CcSEcCtD
Diclofenac—Somnolence—Methotrexate—breast cancer	1.03e-05	7.31e-05	CcSEcCtD
Diclofenac—Dizziness—Capecitabine—breast cancer	1.03e-05	7.3e-05	CcSEcCtD
Diclofenac—Dry mouth—Doxorubicin—breast cancer	1.03e-05	7.26e-05	CcSEcCtD
Diclofenac—Vomiting—Docetaxel—breast cancer	1.02e-05	7.25e-05	CcSEcCtD
Diclofenac—Dyspepsia—Methotrexate—breast cancer	1.02e-05	7.24e-05	CcSEcCtD
Diclofenac—Rash—Docetaxel—breast cancer	1.02e-05	7.19e-05	CcSEcCtD
Diclofenac—Hypotension—Epirubicin—breast cancer	1.02e-05	7.19e-05	CcSEcCtD
Diclofenac—Dermatitis—Docetaxel—breast cancer	1.02e-05	7.19e-05	CcSEcCtD
Diclofenac—Confusional state—Doxorubicin—breast cancer	1.01e-05	7.18e-05	CcSEcCtD
Diclofenac—Decreased appetite—Methotrexate—breast cancer	1.01e-05	7.15e-05	CcSEcCtD
Diclofenac—Headache—Docetaxel—breast cancer	1.01e-05	7.15e-05	CcSEcCtD
Diclofenac—Anaphylactic shock—Doxorubicin—breast cancer	1.01e-05	7.12e-05	CcSEcCtD
Diclofenac—Oedema—Doxorubicin—breast cancer	1.01e-05	7.12e-05	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Methotrexate—breast cancer	1e-05	7.1e-05	CcSEcCtD
Diclofenac—Fatigue—Methotrexate—breast cancer	1e-05	7.09e-05	CcSEcCtD
Diclofenac—Infection—Doxorubicin—breast cancer	9.99e-06	7.07e-05	CcSEcCtD
Diclofenac—Pain—Methotrexate—breast cancer	9.94e-06	7.03e-05	CcSEcCtD
Diclofenac—Vomiting—Capecitabine—breast cancer	9.92e-06	7.02e-05	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Epirubicin—breast cancer	9.91e-06	7.01e-05	CcSEcCtD
Diclofenac—Shock—Doxorubicin—breast cancer	9.9e-06	7e-05	CcSEcCtD
Diclofenac—Nervous system disorder—Doxorubicin—breast cancer	9.87e-06	6.98e-05	CcSEcCtD
Diclofenac—Thrombocytopenia—Doxorubicin—breast cancer	9.85e-06	6.97e-05	CcSEcCtD
Diclofenac—Rash—Capecitabine—breast cancer	9.84e-06	6.96e-05	CcSEcCtD
Diclofenac—Insomnia—Epirubicin—breast cancer	9.83e-06	6.96e-05	CcSEcCtD
Diclofenac—Dermatitis—Capecitabine—breast cancer	9.83e-06	6.96e-05	CcSEcCtD
Diclofenac—Tachycardia—Doxorubicin—breast cancer	9.82e-06	6.95e-05	CcSEcCtD
Diclofenac—Headache—Capecitabine—breast cancer	9.78e-06	6.92e-05	CcSEcCtD
Diclofenac—Skin disorder—Doxorubicin—breast cancer	9.77e-06	6.91e-05	CcSEcCtD
Diclofenac—Paraesthesia—Epirubicin—breast cancer	9.76e-06	6.91e-05	CcSEcCtD
Diclofenac—Hyperhidrosis—Doxorubicin—breast cancer	9.73e-06	6.88e-05	CcSEcCtD
Diclofenac—Dyspnoea—Epirubicin—breast cancer	9.69e-06	6.86e-05	CcSEcCtD
Diclofenac—Somnolence—Epirubicin—breast cancer	9.67e-06	6.84e-05	CcSEcCtD
Diclofenac—Anorexia—Doxorubicin—breast cancer	9.59e-06	6.79e-05	CcSEcCtD
Diclofenac—Nausea—Docetaxel—breast cancer	9.58e-06	6.78e-05	CcSEcCtD
Diclofenac—Feeling abnormal—Methotrexate—breast cancer	9.57e-06	6.77e-05	CcSEcCtD
Diclofenac—Dyspepsia—Epirubicin—breast cancer	9.57e-06	6.77e-05	CcSEcCtD
Diclofenac—Gastrointestinal pain—Methotrexate—breast cancer	9.5e-06	6.72e-05	CcSEcCtD
Diclofenac—Decreased appetite—Epirubicin—breast cancer	9.45e-06	6.69e-05	CcSEcCtD
Diclofenac—Hypotension—Doxorubicin—breast cancer	9.4e-06	6.65e-05	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Epirubicin—breast cancer	9.39e-06	6.64e-05	CcSEcCtD
Diclofenac—Fatigue—Epirubicin—breast cancer	9.37e-06	6.63e-05	CcSEcCtD
Diclofenac—Pain—Epirubicin—breast cancer	9.3e-06	6.58e-05	CcSEcCtD
Diclofenac—Constipation—Epirubicin—breast cancer	9.3e-06	6.58e-05	CcSEcCtD
Diclofenac—Nausea—Capecitabine—breast cancer	9.27e-06	6.56e-05	CcSEcCtD
Diclofenac—Urticaria—Methotrexate—breast cancer	9.23e-06	6.53e-05	CcSEcCtD
Diclofenac—Body temperature increased—Methotrexate—breast cancer	9.18e-06	6.5e-05	CcSEcCtD
Diclofenac—Abdominal pain—Methotrexate—breast cancer	9.18e-06	6.5e-05	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Doxorubicin—breast cancer	9.17e-06	6.49e-05	CcSEcCtD
Diclofenac—Insomnia—Doxorubicin—breast cancer	9.1e-06	6.44e-05	CcSEcCtD
Diclofenac—Paraesthesia—Doxorubicin—breast cancer	9.03e-06	6.39e-05	CcSEcCtD
Diclofenac—Dyspnoea—Doxorubicin—breast cancer	8.97e-06	6.35e-05	CcSEcCtD
Diclofenac—Feeling abnormal—Epirubicin—breast cancer	8.96e-06	6.34e-05	CcSEcCtD
Diclofenac—Somnolence—Doxorubicin—breast cancer	8.94e-06	6.33e-05	CcSEcCtD
Diclofenac—Gastrointestinal pain—Epirubicin—breast cancer	8.89e-06	6.29e-05	CcSEcCtD
Diclofenac—Dyspepsia—Doxorubicin—breast cancer	8.86e-06	6.27e-05	CcSEcCtD
Diclofenac—Decreased appetite—Doxorubicin—breast cancer	8.75e-06	6.19e-05	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Doxorubicin—breast cancer	8.69e-06	6.15e-05	CcSEcCtD
Diclofenac—Fatigue—Doxorubicin—breast cancer	8.67e-06	6.14e-05	CcSEcCtD
Diclofenac—Urticaria—Epirubicin—breast cancer	8.64e-06	6.11e-05	CcSEcCtD
Diclofenac—Pain—Doxorubicin—breast cancer	8.6e-06	6.09e-05	CcSEcCtD
Diclofenac—Constipation—Doxorubicin—breast cancer	8.6e-06	6.09e-05	CcSEcCtD
Diclofenac—Abdominal pain—Epirubicin—breast cancer	8.6e-06	6.08e-05	CcSEcCtD
Diclofenac—Body temperature increased—Epirubicin—breast cancer	8.6e-06	6.08e-05	CcSEcCtD
Diclofenac—Hypersensitivity—Methotrexate—breast cancer	8.56e-06	6.06e-05	CcSEcCtD
Diclofenac—Asthenia—Methotrexate—breast cancer	8.34e-06	5.9e-05	CcSEcCtD
Diclofenac—Feeling abnormal—Doxorubicin—breast cancer	8.29e-06	5.87e-05	CcSEcCtD
Diclofenac—Gastrointestinal pain—Doxorubicin—breast cancer	8.23e-06	5.82e-05	CcSEcCtD
Diclofenac—Pruritus—Methotrexate—breast cancer	8.22e-06	5.82e-05	CcSEcCtD
Diclofenac—Hypersensitivity—Epirubicin—breast cancer	8.01e-06	5.67e-05	CcSEcCtD
Diclofenac—Urticaria—Doxorubicin—breast cancer	7.99e-06	5.66e-05	CcSEcCtD
Diclofenac—Abdominal pain—Doxorubicin—breast cancer	7.95e-06	5.63e-05	CcSEcCtD
Diclofenac—Body temperature increased—Doxorubicin—breast cancer	7.95e-06	5.63e-05	CcSEcCtD
Diclofenac—Diarrhoea—Methotrexate—breast cancer	7.95e-06	5.62e-05	CcSEcCtD
Diclofenac—Asthenia—Epirubicin—breast cancer	7.8e-06	5.52e-05	CcSEcCtD
Diclofenac—Pruritus—Epirubicin—breast cancer	7.69e-06	5.44e-05	CcSEcCtD
Diclofenac—Dizziness—Methotrexate—breast cancer	7.68e-06	5.44e-05	CcSEcCtD
Diclofenac—Diarrhoea—Epirubicin—breast cancer	7.44e-06	5.26e-05	CcSEcCtD
Diclofenac—Hypersensitivity—Doxorubicin—breast cancer	7.41e-06	5.24e-05	CcSEcCtD
Diclofenac—Vomiting—Methotrexate—breast cancer	7.39e-06	5.23e-05	CcSEcCtD
Diclofenac—Rash—Methotrexate—breast cancer	7.33e-06	5.18e-05	CcSEcCtD
Diclofenac—Dermatitis—Methotrexate—breast cancer	7.32e-06	5.18e-05	CcSEcCtD
Diclofenac—Headache—Methotrexate—breast cancer	7.28e-06	5.15e-05	CcSEcCtD
Diclofenac—Asthenia—Doxorubicin—breast cancer	7.22e-06	5.11e-05	CcSEcCtD
Diclofenac—Dizziness—Epirubicin—breast cancer	7.19e-06	5.09e-05	CcSEcCtD
Diclofenac—Pruritus—Doxorubicin—breast cancer	7.12e-06	5.04e-05	CcSEcCtD
Diclofenac—Vomiting—Epirubicin—breast cancer	6.91e-06	4.89e-05	CcSEcCtD
Diclofenac—Nausea—Methotrexate—breast cancer	6.9e-06	4.88e-05	CcSEcCtD
Diclofenac—Diarrhoea—Doxorubicin—breast cancer	6.88e-06	4.87e-05	CcSEcCtD
Diclofenac—Rash—Epirubicin—breast cancer	6.86e-06	4.85e-05	CcSEcCtD
Diclofenac—Dermatitis—Epirubicin—breast cancer	6.85e-06	4.85e-05	CcSEcCtD
Diclofenac—Headache—Epirubicin—breast cancer	6.81e-06	4.82e-05	CcSEcCtD
Diclofenac—Dizziness—Doxorubicin—breast cancer	6.65e-06	4.71e-05	CcSEcCtD
Diclofenac—Nausea—Epirubicin—breast cancer	6.46e-06	4.57e-05	CcSEcCtD
Diclofenac—Vomiting—Doxorubicin—breast cancer	6.4e-06	4.53e-05	CcSEcCtD
Diclofenac—Rash—Doxorubicin—breast cancer	6.34e-06	4.49e-05	CcSEcCtD
Diclofenac—Dermatitis—Doxorubicin—breast cancer	6.34e-06	4.48e-05	CcSEcCtD
Diclofenac—Headache—Doxorubicin—breast cancer	6.3e-06	4.46e-05	CcSEcCtD
Diclofenac—Nausea—Doxorubicin—breast cancer	5.98e-06	4.23e-05	CcSEcCtD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	8.03e-07	7.66e-06	CbGpPWpGaD
Diclofenac—ABCC1—Disease—MYC—breast cancer	7.98e-07	7.61e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—GSTM1—breast cancer	7.98e-07	7.6e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PLA2G4A—breast cancer	7.98e-07	7.6e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—NCOR1—breast cancer	7.98e-07	7.6e-06	CbGpPWpGaD
Diclofenac—ABCC1—Disease—TGFB1—breast cancer	7.96e-07	7.59e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—COMT—breast cancer	7.95e-07	7.58e-06	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—CAV1—breast cancer	7.95e-07	7.58e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	7.94e-07	7.57e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—ABCG2—breast cancer	7.92e-07	7.55e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CPT1A—breast cancer	7.92e-07	7.55e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—MTR—breast cancer	7.92e-07	7.55e-06	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—KRAS—breast cancer	7.91e-07	7.55e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—GSTP1—breast cancer	7.91e-07	7.55e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—CYP3A4—breast cancer	7.91e-07	7.54e-06	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—MTHFR—breast cancer	7.9e-07	7.53e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—TYMS—breast cancer	7.88e-07	7.51e-06	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PIK3CB—breast cancer	7.87e-07	7.5e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	7.87e-07	7.5e-06	CbGpPWpGaD
Diclofenac—ALB—Metabolism—MTHFR—breast cancer	7.85e-07	7.49e-06	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PIK3CG—breast cancer	7.84e-07	7.47e-06	CbGpPWpGaD
Diclofenac—ABCC1—Disease—EGFR—breast cancer	7.81e-07	7.45e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—HMOX1—breast cancer	7.8e-07	7.44e-06	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PTGS2—breast cancer	7.8e-07	7.44e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—ITPR1—breast cancer	7.79e-07	7.42e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—GSTM1—breast cancer	7.78e-07	7.42e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—NCOR1—breast cancer	7.78e-07	7.42e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PLA2G4A—breast cancer	7.78e-07	7.42e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—CYP1B1—breast cancer	7.77e-07	7.41e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—HPGDS—breast cancer	7.76e-07	7.4e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—HBA1—breast cancer	7.71e-07	7.36e-06	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PIK3CG—breast cancer	7.68e-07	7.32e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—MDM2—breast cancer	7.67e-07	7.31e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—RAF1—breast cancer	7.64e-07	7.29e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—GPX1—breast cancer	7.64e-07	7.28e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—HSP90AA1—breast cancer	7.62e-07	7.27e-06	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—PIK3CA—breast cancer	7.6e-07	7.25e-06	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	7.59e-07	7.24e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—CYP1A1—breast cancer	7.56e-07	7.21e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—ERBB2—breast cancer	7.56e-07	7.21e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—GSTT1—breast cancer	7.53e-07	7.18e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—ACHE—breast cancer	7.53e-07	7.18e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—ERCC2—breast cancer	7.5e-07	7.15e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—ABCB1—breast cancer	7.49e-07	7.14e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—MTOR—breast cancer	7.46e-07	7.11e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—PIK3CB—breast cancer	7.46e-07	7.11e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—GPX1—breast cancer	7.45e-07	7.11e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—CD4—breast cancer	7.45e-07	7.1e-06	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—PIK3CA—breast cancer	7.45e-07	7.1e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—NCOA1—breast cancer	7.42e-07	7.07e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—CYP1A1—breast cancer	7.38e-07	7.04e-06	CbGpPWpGaD
Diclofenac—ABCC1—Disease—KRAS—breast cancer	7.38e-07	7.03e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—TYMS—breast cancer	7.36e-07	7.02e-06	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—TP53—breast cancer	7.35e-07	7.01e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—ERCC2—breast cancer	7.32e-07	6.98e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—STK11—breast cancer	7.31e-07	6.97e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—CYP19A1—breast cancer	7.31e-07	6.97e-06	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—CAV1—breast cancer	7.28e-07	6.95e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—GSTM1—breast cancer	7.27e-07	6.93e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—NCOR1—breast cancer	7.27e-07	6.93e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PLA2G4A—breast cancer	7.27e-07	6.93e-06	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—PIK3CA—breast cancer	7.27e-07	6.93e-06	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—PIK3CA—breast cancer	7.24e-07	6.91e-06	CbGpPWpGaD
Diclofenac—ALB—Metabolism—CAV1—breast cancer	7.24e-07	6.91e-06	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PIK3CG—breast cancer	7.24e-07	6.9e-06	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PIK3CD—breast cancer	7.17e-07	6.84e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CYP17A1—breast cancer	7.13e-07	6.8e-06	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—ALB—breast cancer	7.08e-07	6.75e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PTGS1—breast cancer	7.06e-07	6.73e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—ENO1—breast cancer	7.06e-07	6.73e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—MTHFR—breast cancer	7.05e-07	6.72e-06	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—TP53—breast cancer	7.03e-07	6.71e-06	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—HRAS—breast cancer	7.03e-07	6.7e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—CDKN1B—breast cancer	7e-07	6.68e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—GPX1—breast cancer	6.96e-07	6.64e-06	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	6.96e-07	6.64e-06	CbGpPWpGaD
Diclofenac—ALB—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	6.92e-07	6.6e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CYP2D6—breast cancer	6.92e-07	6.6e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—CYP1A1—breast cancer	6.89e-07	6.57e-06	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PIK3CD—breast cancer	6.89e-07	6.57e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—MTHFR—breast cancer	6.88e-07	6.56e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	6.86e-07	6.54e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—ERCC2—breast cancer	6.84e-07	6.52e-06	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—ALB—breast cancer	6.8e-07	6.49e-06	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PTEN—breast cancer	6.8e-07	6.49e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—COMT—breast cancer	6.79e-07	6.48e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—NCOA2—breast cancer	6.79e-07	6.48e-06	CbGpPWpGaD
Diclofenac—ABCC1—Disease—PIK3CA—breast cancer	6.78e-07	6.46e-06	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—NOS3—breast cancer	6.77e-07	6.45e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—GSTP1—breast cancer	6.76e-07	6.45e-06	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PIK3CD—breast cancer	6.75e-07	6.43e-06	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—HRAS—breast cancer	6.73e-07	6.41e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—HMOX1—breast cancer	6.67e-07	6.36e-06	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—ALB—breast cancer	6.66e-07	6.35e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—ITPR1—breast cancer	6.65e-07	6.34e-06	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PIK3CG—breast cancer	6.63e-07	6.33e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—CTNNB1—breast cancer	6.61e-07	6.31e-06	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PIK3CG—breast cancer	6.6e-07	6.29e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—FASN—breast cancer	6.59e-07	6.28e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—BCHE—breast cancer	6.56e-07	6.25e-06	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—NOS3—breast cancer	6.51e-07	6.2e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—CAV1—breast cancer	6.5e-07	6.2e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—SLC5A5—breast cancer	6.48e-07	6.18e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—CDKN1A—breast cancer	6.46e-07	6.16e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—PTEN—breast cancer	6.45e-07	6.15e-06	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—IL6—breast cancer	6.44e-07	6.14e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—MTHFR—breast cancer	6.43e-07	6.13e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—ABCB1—breast cancer	6.4e-07	6.1e-06	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—NOS3—breast cancer	6.37e-07	6.08e-06	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PIK3CD—breast cancer	6.36e-07	6.07e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—CAV1—breast cancer	6.35e-07	6.05e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—TYMS—breast cancer	6.29e-07	5.99e-06	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—ALB—breast cancer	6.28e-07	5.99e-06	CbGpPWpGaD
Diclofenac—ABCC1—Disease—HRAS—breast cancer	6.27e-07	5.98e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—SLC2A1—breast cancer	6.26e-07	5.97e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—NQO1—breast cancer	6.26e-07	5.97e-06	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PIK3CB—breast cancer	6.25e-07	5.96e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—GSTM1—breast cancer	6.21e-07	5.93e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PLA2G4A—breast cancer	6.21e-07	5.93e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—NCOR1—breast cancer	6.21e-07	5.93e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	6.21e-07	5.92e-06	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—AKT1—breast cancer	6.21e-07	5.92e-06	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—AKT1—breast cancer	6.08e-07	5.8e-06	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—NOS3—breast cancer	6.01e-07	5.73e-06	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PIK3CB—breast cancer	6.01e-07	5.73e-06	CbGpPWpGaD
Diclofenac—ABCC1—Disease—IL6—breast cancer	6e-07	5.72e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CYP1B1—breast cancer	6e-07	5.72e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—SRC—breast cancer	5.98e-07	5.7e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—GPX1—breast cancer	5.95e-07	5.67e-06	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PTGS2—breast cancer	5.95e-07	5.67e-06	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—AKT1—breast cancer	5.94e-07	5.66e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—CAV1—breast cancer	5.93e-07	5.65e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PIK3CG—breast cancer	5.92e-07	5.65e-06	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—AKT1—breast cancer	5.92e-07	5.64e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—CYP1A1—breast cancer	5.89e-07	5.62e-06	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—PIK3CA—breast cancer	5.89e-07	5.61e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—HSP90AA1—breast cancer	5.88e-07	5.61e-06	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PIK3CB—breast cancer	5.88e-07	5.61e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—ERCC2—breast cancer	5.84e-07	5.57e-06	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PIK3CD—breast cancer	5.83e-07	5.56e-06	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PTGS2—breast cancer	5.83e-07	5.56e-06	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PIK3CD—breast cancer	5.8e-07	5.53e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PIK3CG—breast cancer	5.78e-07	5.51e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—STAT3—breast cancer	5.77e-07	5.5e-06	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—ALB—breast cancer	5.76e-07	5.49e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—NCOA1—breast cancer	5.72e-07	5.46e-06	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—PIK3CA—breast cancer	5.68e-07	5.41e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	5.66e-07	5.4e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CYP19A1—breast cancer	5.64e-07	5.38e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—STK11—breast cancer	5.64e-07	5.38e-06	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PIK3CB—breast cancer	5.55e-07	5.29e-06	CbGpPWpGaD
Diclofenac—ABCC1—Disease—AKT1—breast cancer	5.54e-07	5.28e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—MAPK3—breast cancer	5.51e-07	5.25e-06	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—NOS3—breast cancer	5.51e-07	5.25e-06	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PTGS2—breast cancer	5.49e-07	5.24e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—MTHFR—breast cancer	5.49e-07	5.24e-06	CbGpPWpGaD
Diclofenac—ALB—Metabolism—NOS3—breast cancer	5.48e-07	5.22e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PIK3CG—breast cancer	5.4e-07	5.15e-06	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PTEN—breast cancer	5.4e-07	5.15e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—MYC—breast cancer	5.36e-07	5.11e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—TGFB1—breast cancer	5.34e-07	5.1e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—COMT—breast cancer	5.24e-07	5e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—EGFR—breast cancer	5.24e-07	5e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—GSTP1—breast cancer	5.22e-07	4.98e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PIK3CD—breast cancer	5.21e-07	4.96e-06	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PTEN—breast cancer	5.19e-07	4.95e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—HMOX1—breast cancer	5.15e-07	4.91e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—ALB—breast cancer	5.14e-07	4.9e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—ITPR1—breast cancer	5.14e-07	4.9e-06	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PIK3CB—breast cancer	5.08e-07	4.85e-06	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PTEN—breast cancer	5.08e-07	4.85e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PIK3CD—breast cancer	5.08e-07	4.85e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—CAV1—breast cancer	5.07e-07	4.83e-06	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PIK3CB—breast cancer	5.06e-07	4.82e-06	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PTGS2—breast cancer	5.04e-07	4.8e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—ALB—breast cancer	5.02e-07	4.78e-06	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PTGS2—breast cancer	5.01e-07	4.78e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—KRAS—breast cancer	4.95e-07	4.72e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—ABCB1—breast cancer	4.94e-07	4.71e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—NOS3—breast cancer	4.92e-07	4.69e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—TYMS—breast cancer	4.85e-07	4.63e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	4.84e-07	4.61e-06	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—AKT1—breast cancer	4.81e-07	4.58e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—NOS3—breast cancer	4.8e-07	4.58e-06	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PIK3CA—breast cancer	4.8e-07	4.57e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—GSTM1—breast cancer	4.8e-07	4.57e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PLA2G4A—breast cancer	4.8e-07	4.57e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—NCOR1—breast cancer	4.8e-07	4.57e-06	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PTEN—breast cancer	4.79e-07	4.57e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PIK3CD—breast cancer	4.75e-07	4.53e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—ALB—breast cancer	4.69e-07	4.47e-06	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—AKT1—breast cancer	4.64e-07	4.42e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PIK3CG—breast cancer	4.61e-07	4.4e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—GPX1—breast cancer	4.59e-07	4.38e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—PIK3CA—breast cancer	4.55e-07	4.34e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CYP1A1—breast cancer	4.55e-07	4.34e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PIK3CB—breast cancer	4.54e-07	4.33e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—ERCC2—breast cancer	4.51e-07	4.3e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PTGS2—breast cancer	4.5e-07	4.29e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—NOS3—breast cancer	4.48e-07	4.27e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PIK3CB—breast cancer	4.43e-07	4.22e-06	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PTEN—breast cancer	4.39e-07	4.19e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PTGS2—breast cancer	4.39e-07	4.18e-06	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PTEN—breast cancer	4.37e-07	4.17e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—MTHFR—breast cancer	4.24e-07	4.04e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—HRAS—breast cancer	4.21e-07	4.01e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PIK3CB—breast cancer	4.14e-07	3.95e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PTGS2—breast cancer	4.1e-07	3.91e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PIK3CD—breast cancer	4.06e-07	3.87e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—IL6—breast cancer	4.03e-07	3.84e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—ALB—breast cancer	4e-07	3.82e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PTEN—breast cancer	3.92e-07	3.74e-06	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—AKT1—breast cancer	3.92e-07	3.74e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CAV1—breast cancer	3.91e-07	3.73e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—NOS3—breast cancer	3.83e-07	3.65e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PTEN—breast cancer	3.83e-07	3.65e-06	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PIK3CA—breast cancer	3.81e-07	3.63e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—AKT1—breast cancer	3.72e-07	3.54e-06	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PIK3CA—breast cancer	3.66e-07	3.49e-06	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PIK3CA—breast cancer	3.59e-07	3.42e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PTEN—breast cancer	3.58e-07	3.41e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PIK3CG—breast cancer	3.56e-07	3.4e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PIK3CB—breast cancer	3.54e-07	3.37e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PTGS2—breast cancer	3.5e-07	3.34e-06	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PIK3CA—breast cancer	3.38e-07	3.22e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PIK3CD—breast cancer	3.13e-07	2.99e-06	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—AKT1—breast cancer	3.11e-07	2.97e-06	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PIK3CA—breast cancer	3.1e-07	2.96e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—ALB—breast cancer	3.09e-07	2.95e-06	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PIK3CA—breast cancer	3.08e-07	2.94e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PTEN—breast cancer	3.06e-07	2.91e-06	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—AKT1—breast cancer	2.99e-07	2.85e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—NOS3—breast cancer	2.96e-07	2.82e-06	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—AKT1—breast cancer	2.93e-07	2.79e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PIK3CA—breast cancer	2.77e-07	2.64e-06	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—AKT1—breast cancer	2.76e-07	2.63e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PIK3CB—breast cancer	2.73e-07	2.6e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PTGS2—breast cancer	2.7e-07	2.58e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PIK3CA—breast cancer	2.7e-07	2.57e-06	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—AKT1—breast cancer	2.53e-07	2.41e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PIK3CA—breast cancer	2.52e-07	2.41e-06	CbGpPWpGaD
Diclofenac—ALB—Metabolism—AKT1—breast cancer	2.52e-07	2.4e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PTEN—breast cancer	2.36e-07	2.25e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—AKT1—breast cancer	2.26e-07	2.15e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—AKT1—breast cancer	2.21e-07	2.1e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PIK3CA—breast cancer	2.16e-07	2.06e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—AKT1—breast cancer	2.06e-07	1.96e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—AKT1—breast cancer	1.76e-07	1.68e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PIK3CA—breast cancer	1.66e-07	1.59e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—AKT1—breast cancer	1.36e-07	1.3e-06	CbGpPWpGaD
